Skip to main content

Table 3 LV function, myocardial strain and native T1 value of ESRD with targeted iPTH and with increased iPTH

From: The association of secondary hyperparathyroidism and myocardial damages in hemodialysis end-stage renal disease patients: assessed by cardiovascular magnetic resonance native T1 mapping

  Normal subjects (n = 30) ESRD with targeted iPTH (n = 32) ESRD with increased iPTH (n = 40)
LV function    
 EF (%) 65.0 ± 4.5 55.9 ± 12.0* 51.7 ± 12.8*
 EDV (mL) 117 ± 31 128 ± 44 134 ± 50
 ESV (mL) 45 ± 13 60 ± 44 69 ± 47*
 SV (mL) 79 ± 17 67 ± 18 65 ± 18
 LV mass (g) 52 ± 17 85 ± 31* 90 ± 32*
 EDV/BSA (mL/mm2) 72.3 ± 20.1 83.3 ± 26.4 84.8 ± 36.3
 ESV/BSA (mL/m2) 260.0 ± 5.5 38.9 ± 26.4 43.8 ± 34.4 *
 SV/BSA (mL/m2) 48.6 ± 11.2 44.2 ± 11.6 40.3 ± 10.9*
 Mass/BSA (g/m2) 32.2 ± 11.4 54.4 ± 19.0* 56.3 ± 19.0*
Myocardial strain parameters    
 PRS 43.0 ± 9.8 43.2 ± 14.9 37.6 ± 15.7
 PCS − 18.3 ± 2.1 − 17.8 ± 4.2 − 16.8 ± 5.0
 PLS − 16.5 ± 2.4 − 15.7 ± 3.7 − 14.8 ± 4.4
Native T1 value    
 Basal segment 1238 ± 36 1304 ± 41* 1330 ± 43*#
 Middle segment 1242 ± 50 1300 ± 43* 1323 ± 43*#
 Apical segment 1280 ± 65 1339 ± 86 1360 ± 74*
Global 1251 ± 49 1305 ± 41* 1334 ± 40*#
  1. LV left ventricular, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, SV stroke volume, PRS peak radial strain, PCS peak circumferential strain, PLS peak longitudinal strain directions, BSA body surface area. Other abbreviations are the same as Tables 1 and 2
  2. *P < 0.05 vs. normal group; #P < 0.05 vs. comparison with ESRD with targeted iPTH